Background: Gold nanoparticles (GNPs) and their functional derivatives are of great interest because of their many biomedical applications. GNPs are increasingly being incorporated into new diagnostic and therapeutic approaches in medicine. Consequently, there has been a strong push to fully understand their interactions with blood components. The agglomeration of cells reflects the interaction of nanoparticles with blood components.
Introduction
Gold-based nanoparticles (GNPs) have been widely used for various biomedical purposes (eg, biosensors, optical imaging, drug-delivery, and photothermal therapy). These uses of GNPs are made possible due to their surface chemistry and optical characteristics. In considering these uses, the biocompatibility and non-toxic nature 
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Patlolla et al of GNPs are vital. Once GNPs enter the body, they can be translocated through the blood to accessory target organs such as the liver, spurring adverse biological reactions. 1 Despite their significant potential environmental, biomedical, and industrial applications, there are very limited data on corresponding acute and chronic health responses in humans and the environment. Consequently, there are no safety and regulatory guidelines concerning the manufacture and application of nanomaterials. 2 The in vivo biocompatibility of GNP has been widely investigated. Concerns regarding GNP blood compatibility have been raised due to its increased use in biomedical applications. Some attributes that have been closely related to the toxicity of GNPs include their surface chemistry, physical dimensions, doses, and routes of administration. Modifications of GNPs with different functional groups such as citrate, tannic acid, polyvinylpyrrolidone, polyvinyl alcohol, silica, and amine-terminated silica including polyethylene glycol (PEG) have been shown to alter cell-particle interactions, ensuring system stability and biocompatibility. Several studies 3, 4 have reported that uncoated GNPs are unstable under physiological conditions and are able to agglomerate in blood through interactions with proteins. These agglomerates have been shown to reach the liver and spleen via rapid absorption through the reticuloendothelial system. (PEG)-coated GNP has been found to reduce surface charges (zeta potential) and improve the blood stability of GNPs. 5 In addition, they are found in monodisperse distributions under physiological conditions with an extensive half-life; thus, they are constantly found in circulating blood. Despite these positive qualities, PEG-coated GNPs are still capable of being toxic to the liver and kidneys and to spurring gene expression from accumulation in these tissues.
As GNPs accumulate in these tissues, they have been shown to produce reactive oxygen species (ROS) and to mainly cause oxidative stress when the chemical reaction conditions of cells are overloaded. [6] [7] [8] [9] ROS generation is a normal physiological process implicated in various forms of cellular signaling, including defense mechanisms of the immune system. However, in surplus it can cause serious injury to cellular macromolecules such as proteins, lipids, and DNA. The quantity of ROS generated by GNPs has been shown to be a function of diameter and surface area. The smaller the diameter and larger the surface area, the more the ROS that is generated. GNPs of 5-250 nm have disclosed an inverse association between smaller diameter and larger surface area nanoparticles in generating elevated quantities of ROS. 10 In spite of this, the relationship between GNP and oxidative stress is not well understood.
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The liver is a vital organ that is essential to sustaining life in many organisms due to its numerous functions. Most notably, the liver produces proteins including those involved in blood clotting. The liver is also responsible for the detoxification of blood and for the metabolism of nutrients from the digestive tract. Consequently, the impairment of liver function can have very serious effects. 12 There are multiple means of measuring hepatotoxicity. Alanine (ALT) and aspartate (AST) aminotransferases are considered to be markers of direct cellular injury to hepatocytes. ALT is considered a more specific marker than AST. 1, 12 Alkaline phosphatase (ALP) is another marker correlated with cholestatic or congestive problems in the liver. These problems can either occur secondary to liver injury or can progress to liver injury due to obstruction. Measuring the levels of such enzymes in the blood has become a widely used approach for assessing hepatotoxicity over the past 25 years. 13 This study assesses the effects, after oral administration of PEG-coated and uncoated GNPs, on ROS induction, on levels of various hepatotoxicity biomarkers (ALT/AST; ALP), and on histopathology changes of liver tissues in the rat model. The question of the health effects of GNPs is quite acute, and this study brings new data in a field where the largest proportion of publications have been conducted with non-comparative models. The few studies involving oral delivery of GNPs focus on the possible oral absorption in gastrointestinal tract, or on pharmacokinetics. The liver is one of the recurrent target organs found after oral, intravenous (iv), or intraperitoneal (ip) injection of GNPs in diverse publications and even sometimes the dominant site of accumulation. Therefore, the results presented here are of importance for health risk assessment. 
Materials and methods
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Peg-coated and uncoated gNP-mediated hepatotoxicity and oxidative stress Sprague Dawley rats (6-8 weeks of age, with an average body weight (BW) of 100±2 g). Animals were allowed to adapt to the animal housing for 1 week prior to the experiments. The rats were indiscriminately chosen and accommodated in polycarbonate cages (18. 88 in × 7.25 in × 3.76 in) (three rats per cage) with steel wire tops and corn-cob bedding. They were retained in a supervised atmosphere with a 12-hour dark/12-hour light cycle, a temperature of 22°C±2°C, and humidity levels of 50%-70%. Free access to food (standard rat pellets, Sniff [oval normal diet of balanced nutritional value for biomedical research]) and fresh tap water was made available to the rats.
The animal protocols used in this work were evaluated and approved by the Animal Use and Ethic Committee (CEUA) of the 0804 (Ethical Approval Code). They are in accordance with FELASA guidelines and with the National Law for Laboratory Animal Experimentation (Law no 18.611). 28 
experimental design
Four distinct doses of PEG-coated and uncoated GNPs (12.5, 25, 50, and 100 µg/kg BW) were used. Each group consisted of three rats receiving oral administrations of PEG-coated and uncoated GNPs, given for 5 days at one dose per 24 hours. The control group included three rats that received deionized water. All experiments were regulated in compliance with the National and Institutional guidelines for the care and use of animals in biomedical research. 14 To determine the morphological size of PEG-coated and uncoated GNPs (Figure 1 ), a transmission electron microscope (TEM) was utilized. A drop of homogeneously dispersed GNP was suspended on a copper grid with lacey carbon film and was allowed to air dry. The images of both types of GNPs were captured using a field emission JEOL-JEM-2100F, TEM, operating at 200 KV (JEOL, Tokyo, Japan).
To determine the size and zeta potential of PEG-coated and uncoated GNPs, a Nano Zetasizer (Malvern Instruments, Malvern, UK) was used. To obtain a homogenous dispersion of nanoparticles, a stock solution of 50 µg/mL of GNPs was diluted, vortexed, and sonicated for 5 minutes. One milliliter of the diluted GNPs dispersion was transferred to a 1 cm cuvette for dynamic size measurements of both GNPs. A Malvern zeta potential cell was utilized to measure zeta potential values. The cell was rinsed 3-4 times with ultrapure water before transferring 850 µL of the diluted GNPs dispersion into it. GNPs were used as a positive control to authenticate the instrument. Each measurement was collected three times and specifics acquired were determined as the average size or zeta potential of GNPs.
liver homogenate preparation Livers exposed to PEG-coated and uncoated GNPs were excised under anesthesia after 5 days of exposure. A 10% homogenate of liver tissue was formulated in a solution of 0.05 M phosphate buffer (pH 7.4) and 0.01 mM EDTA. The liver tissue was homogenized using a motor-driven Teflonpestle homogenizer (Thermo Fisher Scientific, Waltham, MA, USA), followed by sonication (Branson Sonifier) and centrifugation at 500× g for 10 minutes at 4°C. The supernatant was transferred and centrifuged at 2,000× g for 60 minutes at 4°C. Following centrifugation, cellular fragments were collected and utilized as homogenate for assessment.
Detection of rOs
The manufacturer's protocol for DCFH-DA (2′7′ dichlorofluorescin diacetate) with slight modifications was followed to analyze ROS production. 15 Samples were measured using a Fluorescence Plate Reader (Turner Biosystems, Sunnyvale, CA, USA) for which peak excitation wavelengths for oxidized DCFH were set at 488 nm and emission wavelengths at 525 nm. The calibration of the fluorometry process was executed using standard curves for serial dilutions of fluorescein. The samples underwent serial dilutions of metal-contaminant free hydrogen peroxide (Merck, Darmstadt, Germany) and were incubated. The oxidation of DCFH was then measured per µM H 2 O 2 . Samples loaded with DCFH-DA were deducted by their appropriate controls to measure accurate DCFH oxidation levels of the liver samples.
collection of serum
Samples of blood were collected in heparin containing tubes 24 hours after the last treatment following normal protocols. A sample of blood from each group was allowed to clot 
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Patlolla et al for 30 minutes, followed by centrifugation (750× g for 15 minutes). Serum was drained from cellular elements and transferred to an acid-washed polypropylene tube properly labeled and stored until further assessment. Colorimetric assay kits were utilized to measure levels of alanine (ALA) and aspartate (ASP) aminotransferases, and alkaline phosphatase (ALP) in the serum.
serum aminotransferases
Methods developed by Reitman and Franke 16 were used to measure alanine or glutamate pyruvate transaminase (ALT/ GPT) and aspartate or glutamate oxaloacetate transaminase (AST/GOT) levels in the serum. While several types of transaminases are present in human serum, ALT/GPT and AST/GOT are the two most frequently measured enzymes. The mechanism involved in the activities of these enzymes involves the catalyzed transfer of alpha-amino groups from specific amino acids to alpha-ketoglutaaric acid (AKG) to yield respective end products glutamic and oxaloacetice acid. 2, 4-dinitrophenyl hydrazine reactivity with keto acids was detected using a colorimetric assay kit. At a wavelength of ~505 nm, the absorbance of the resulting color was determined to have beneficial effects on absorption between hydrazones of AKG and hydrazones of oxaloacetic or pyruvic acid.
analysis of alkaline phosphatases
A method developed by Kay et al 17 was employed to evaluate the activity of ALP in serum using a diagnostic kit developed by Sigma-Aldrich Co. The mechanism involved in relies on the hydrolysis of p-nitrophenyl phosphate by the enzyme, generating p-nitrophenol and inorganic phosphate. When made alkaline, p-nitrophenol is converted into a yellow complex that is readily measured at a wavelength of 400-420 nm. Phosphatase activity has been shown to be directly proportional to the intensity of color formed.
histology of liver
For morphological analysis, liver (same lobe) tissues were isolated from control and exposed rats under anesthesia, were rinsed with ice-cold normal saline (0.9% NaCl) and 20 mM EDTA to remove blood, were fixed using 10% formalin for 48 hours, and were embedded in paraffin. The liver sections were stained using H&E. The percentage of hepatic pathological alterations was evaluated via semiquantitative estimation. Ten slides of each sample were scored for liver histology. The following criteria were used to score liver morphologies: 0 = no hepatocyte damage (normal), 1 = mild hepatocyte damage, 2 = moderate hepatocyte damage, 3 = extensive hepatocyte damage.
statistical analysis
A statistical analysis was performed with SAS 9.1 software for Windows XP. Mean ± SDs were presented as data. Oneway ANOVA P-values of ,0.05 were considered statistically significant. Dunnett's t-test was used for the post hoc evaluation of data.
Results
Nanomaterial characterization
PEG-coated and uncoated GNPs were characterized using a TEM (JEOL-1011) (Figure 1 ) to understand morphologies, diameters, tendencies of aggregation, and cellular distributions. Dynamic light scattering (DLS) was employed for both GNP samples (Figure 2A and B) to study the dispersion of particles when placed into deionized water. According to results obtained through the DLS and TEM analysis of aqueous solution, it was determined that both particles range in size from 15 to 35 nm and that the particles are spherically shaped. Zeta potential values of the PEG-coated and uncoated GNPs were found to be -14.5 mV and 54.3 mV, respectively. 
643
Peg-coated and uncoated gNP-mediated hepatotoxicity and oxidative stress 
Distribution of gNPs in rat livers
To determine the localization of GNPs in the livers of rats after 5 days of exposure, a TEM analysis was conducted. GNPs were predominantly found in Kupffer cells of the liver. Figure 3 presents a photomicrograph of the uptake of GNP.
rOs detection
PEG-coated and uncoated GNPs elevated the induction of ROS in the exposed rats relative to the negative control. The highest two doses, 50 and 100 µg/kg, produced a statistically remarkable difference in the generation of ROS in both types of GNPs relative to the negative control. Experimental data on the intracellular generation of ROS in rats exposed to PEG-coated and uncoated GNPs and for the negative control are shown in Figure 4 . However, more ROS production was observed in uncoated GNPs than in PEG-coated GNPs relative to that of the negative control.
alanine aminotransferase
As shown in Figure 5 , we observed a dose-dependent increase in alanine activity (ALT/GPT) in PEG-coated and uncoated GNPs relative to the negative control. However, two high level doses, 50 and 100 µg/kg, produced a statistically significant outcome in elevating the activity of ALT/GPT relative to the negative control. ALT activity was elevated to a greater extent in uncoated GNPs than in PEG-coated GNPs relative to the negative control.
aspartate aminotransferases PEG-coated and uncoated GNP exposure in rats increased AST/GOT activity levels relative to the negative control. Figure 6 shows experimental data acquired from assays of AST/GOT activity. As shown in the figure, the highest doses of 50 µg/kg and 100 µg/kg presented a statistically notable variation in enhancing the activity of AST/GOT in both types of GNPs relative to the negative control. However, uncoated GNP responded more strongly than PEG-coated GNPs.
alkaline phosphatases Figure 7 reflects the activity of ALP exposed to PEG-coated and uncoated GNPs. An elevation in the activity of ALPs in 
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Patlolla et al samples exposed to either type of GNP did not reveal any evidence of inflammation. For the negative control group, a histological evaluation revealed a normal liver structure of compactly arranged hepatocytes. Sinusoids were randomly dispersed among hepatocytes and had consistent morphology along the central vein.
Rats dosed with 12.5, 25, 50, and 100 µg/kg of PEGcoated and uncoated GNPs underwent unique morphological changes. Figure (8Aa) is the photomicrograph of negative control (0) in rat livers exposed to uncoated GNPs. Damage to the central vein was observed through microscopic evaluations of rat livers exposed to 12.5 µg/kg (Figure 8Ab ) of uncoated GNP. The incomplete disturbance of central veins and vacuolation in hepatocytes (Figure 8Ac and 8Bc, PEG-coated and uncoated GNPs) were observed in rat livers exposed to 25 µg/kg (Figure 8Ac ) of uncoated GNP. In addition to the above-mentioned changes, liver degeneration (atrophy), injury to the central vein, and necrosis ( Figure 8Ad , PEG-coated and uncoated GNPs) were observed in 50 µg/kg GNP exposed rat livers. In rat livers treated with 100 µg/kg of uncoated GNP, central vein impairment, necrosis (Figure 8Ae , uncoated GNP), and pyknotic or condensed nuclei (Figure 8Be , PEG-coated GNP) were observed. Figure 8A shows photomicrographs of rat livers exposed to uncoated GNP and the negative control.
According to a microscopic examination of the PEGcoated exposed rats, liver samples showed less damage than the uncoated samples. Figure 8Ba shows the negative controls of rat livers exposed to PEG-coated GNP. In 12.5 µg/kg (Figure 8Bb ) PEG-coated livers, no morphological changes were observed, echoing results found for the negative control. Damage to the central vein was observed in 25 µg/kg ( Figure 8Bc ) exposed livers. In addition to the above-mentioned changes, vacuolation in hepatocytes and natural cell death were observed in 50 µg/kg (Figure 8Bd ) GNP exposed rat livers. In 100 µg/kg (Figure 8Be ) group receiving PEG-coated GNPs, damage to the central vein, cell death, and pyknotic cells (Figure 8Be ; PEG-coated GNP) were observed. Figure 8B shows photomicrographs of rat livers exposed to PEG-coated GNP and the negative control.
However, uncoated GNPs underwent enhanced morphological changes relative to those of PEG-coated GNPs indicating that PEGylation may be used to improve the biocompatibility of GNPs used in a wide variety of biomedical applications.
Discussion
Comparative effects of PEG-coated and uncoated GNPsmediated hepatotoxicity and oxidative stress were examined rats treated with both types of GNPs relative to the negative control is shown in Figure 7 . However, three concentrations (25, 50, and 100 µg/kg) showed statistically significant effects in elevating ALP activity in both PEG-coated and uncoated GNPs relative to the negative control. ALP activity was elevated more in uncoated GNPs than in PEG-coated GNPs.
histopathological evaluation
The toxicity of PEG-coated and uncoated GNPs was examined via H&E staining. A histological evaluation of liver 
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Peg-coated and uncoated gNP-mediated hepatotoxicity and oxidative stress in Sprague Dawley rats. Oxidative stress was determined by the amount of ROS produced; hepatotoxicity was characterized by ALT, AST, and ALP levels in serum; and from histopathological evaluations of liver samples.
In the liver, Kupffer cells play a significant role in its physiology and in maintaining equilibrium. Kupffer cells' activation by toxins results in the release of a series of inflammatory mediators, growth factors, and ROS 18 that cause hepatocyte injury. To understand mechanisms of liver injury, we must understand the state of diverse responses displayed by Kupffer cells. 19 Levels of ROS production observed in liver homogenates of all four experimental groups were analyzed by identifying oxidation-induced fluorescence emitted by the H 2 DCFDA dye. The induction of ROS was elevated in rats exposed to PEG-coated and uncoated GNPs relative to the negative control. As reported in Figure 4 , doses of 50 and 100 µg/kg GNPs applied to both types showed a statistically significant difference in the induction of ROS compared to the negative control. However, uncoated GNPs were shown to induce more ROS than PEG-coated GNPs. ROS has been found in many studies to produce an inflammatory state that promotes apoptosis across a diverse range of cell types. 20, 21 The best indicator for liver toxicity or damage is an elevation in serum ALT, AST, and ALP levels. These enzymes are contained in hepatocytes, and are released in the blood stream when cells are damaged. The biochemical measurement of these enzymes in serum assesses liver function failure, hepatocellular injury, and cholestasis. In our study, PEG-coated and uncoated GNP exposure resulted in an elevation of ALT and AST levels relative to the negative control. As is shown in Figures 5 and 6 , doses of 50 and 100 µg/kg of both types of GNPs established a statistically significant difference in elevating ALT and AST activity relative to the negative control. However, uncoated GNP was shown to induce more damage than PEG-coated GNPs. In the cell lining of the liver, small bile ducts (ductoles) are responsible for ALP generation. ALP is the main enzyme that is known to elevate when liver disease is obstructive or cholestatic. In our study 25, 50, and 100 µg/kg doses of PEGcoated and uncoated GNPs exhibited a statistically significant difference in elevating ALP levels in serum compared to the negative control. Again, uncoated GNP was found to elevate ALP levels more than PEG-coated GNPs. Similar results have been reported by other investigators who found increased activity in these enzymes after GNP exposure. 1, 12, 22 The enzyme 
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Patlolla et al activity in these studies was found to be much more higher than in our study, which may be due to the route of exposure. Histopathological evaluations of livers exposed to PEG-coated and uncoated GNPs revealed significant morphological variations, such as damage to the central vein; vacuolation in hepatocytes (Figure 8Ac , uncoated GNP and 8D, PEG-coated GNP), pyknosis (Figure 8Be , PEGcoated GNP) or karyomegaly; or condensed hepatocytes' nuclei and necrosis (Figure 8Ae , uncoated GNP) compared to the negative control. The results of microscopic examinations of livers exposed to PEG-coated and uncoated GNPs are reported in Figure 8A and B. Both types of GNPs induced damage to the liver relative to the negative control. We found that uncoated GNP caused more damage than PEG-coated GNP. Corresponding outcomes have been published by Hwang et al 12 as a result of studies of healthy and damaged livers of rodents during GNP-induced hepatotoxicity.
The modification of cell-particle interactions through the functionalization of GNP with ligands such as PEG (PEGylation) is known to stabilize blood components. The outcomes of our work are in agreement with Lipka et al's 5 results which show a reduction in surface charges and an improvement in blood stability resulting from the PEGylation of GNPs. Since uncoated GNPs are susceptible to aggregation in solution due to high surface area to volume ratio and presence of ionic charges, both of which cause significant changes in their optical properties, uncoated GNPs can easily interact with biological molecules relative to PEG-coated GNPs, making it more damaging or toxic to cells and less stable. In addition to the functionalization of GNP, size is another remarkable modulator of in vivo toxicity. It has been reported that GNPs of size ranging from 5 to 30 nm enhance biochemical indicators; slight damage to the liver is caused by GNPs of 10-60 nm. [23] [24] [25] [26] [27] PEG-coated GNPs of 13.5 nm have been found to accumulate in the liver and spleen. Additionally, GNPs of larger than 100 nm are released from the body, in part, through excretion. 26 In our study, 14.5 nm PEG-coated GNPs and 22.5 nm uncoated GNPs increased the levels of biochemical markers of hepatotoxicity and caused damage to livers in the highest two concentrations (50 and 100 µg/kg), as reported by a study 23 where 5-30 nm GNPs were observed to produce similar effects.
Conclusion
In the present work, we have systematically studied the in vivo acute toxicity of PEG-coated and uncoated GNPs after oral administration. Our results show that uncoated GNP exposure spurs more biochemical serum changes, and ROS induction and injury to liver tissue than PEG-coated GNPs.
Functionalization and GNP size are two factors responsible for the outcomes of our study. Our results demonstrate that PEG-coated GNPs are safer to use in nanomedicinal applications than uncoated GNPs. However, more studies must confirm the outcomes of PEGylation. Currently, there is limited knowledge relating to their environmental toxicity and biological safety.
